Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top San Francisco based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected]
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Christine A. Tsingos
EVP & CFO of Bio-Rad Laboratories
Ms. Christine A. Tsingos is Chief Financial Officer, Executive Vice President of Bio Rad Laboratories Inc. Previously, she was the Chief Operating Officer and Chief Financial Officer at Attest Systems, Inc., a provider of information technology asset discovery and management tools, from August 2002 to November 2002. Prior to that, Ms. Tsingos was a consultant to Attest Systems, Inc. from October 2000 to July 2002. She was the Chief Financial Officer at Tavolo, Inc., an online retailer of gourmet cookware and food, from November 1999 to September 2000, and she was Treasurer, and later Vice President and Treasurer, of Autodesk, Inc., a developer of design software, from May 1990 to November 1999.
Follow Christine A. Tsingos:
About Bio-Rad Laboratories: Bio-Rad Laboratories has played a leading role in the advancement of scientific discovery for over 50 years by providing a broad range of
Joe Selsavage
CFO of Lemonaid Health
Follow Joe Selsavage:
About Lemonaid Health, Metromile: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Gerard van Hamel Platerink
Chief Financial Officer of Genalyte
Board Member at HealthMine, MedAvail Technologies & Genalyte.
Follow Gerard van Hamel Platerink:
About Accuitive Medical Ventures, Genalyte, Redmile Group: Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Shaun Holt
CFO of Berkeley Lights
Shaun joined Berkeley Lights in November 2015 and was appointed Chief Financial Officer in March 2016. Prior to becoming CFO, Shaun was Vice President of Finance. Prior to joining Berkeley Lights, Shaun spent 7 ½ years at Illumina, Inc. heading up various aspects of their Finance organization. His roles included Sr. Director, Global Head of R&D and Business Unit Finance, EMEA Head of Finance, Accounting and Facilities, and Commercial FP&A. He earned a B.S. in Finance from California State University, Stanislaus.
Follow Shaun Holt:
About Berkeley Lights: Berkeley Lights is a provider of research and development services using micro-droplet technology that change the biological processes.
Georgia Erbez
Chief Financial Officer of Harpoon Therapeutics
Georgia Erbez currently works as the Chief Financial Officer for Harpoon Therapeutics. She previously worked at Artelo Biosciences, Inc. as the Member Board Of Directors.
Follow Georgia Erbez:
About Harpoon Therapeutics: Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Steven Schwen
Chief Financial Officer of Vensana Capital
Steve Schwen joined Split Rock Partners at the firm’s inception as Chief Financial Officer. He currently oversees the finance, accounting, operations and human resources activities of the firm. Prior to joining Split Rock Partners, Steve was Chief Financial Officer of St. Paul Venture Capital, which he joined in 1998. Before joining St. Paul Venture Capital, he spent four years in the audit practice of KPMG LLP. He provided audit and consulting services to both public and private financial services companies including investment companies, mutual funds, investment managers and investment banks. Steve became a licensed CPA in the state of Minnesota after earning a BA degree in business administration-accounting at the University of St. Thomas. He is a member of the American Institute of Certified Public Accountants and the Minnesota Society of Certified Public Accountants.
Follow Steven Schwen:
About Split Rock Partners, St. Paul Venture Capital, Vensana Capital: Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Howard Horn
CFO of Vir Biotechnology
Howard Horn is the Chief Financial Officer of VIR. Previously, he led the Financial Planning and Corporate Finance functions at Biogen. Prior to joining Biogen, he held positions of increasing responsibility and was focused on the life sciences as a consultant with McKinsey & Company and as an equity research analyst at UBS. Howard holds an M.B.A from the Wharton School of the University of Pennsylvania and a B.A in Economics from Princeton University.
Follow Howard Horn:
About Vir Biotechnology: Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Robin L. Praeger
CFO, Managing Director of Versant Ventures
Robin and his team have primary responsibility for Versant’s financial, legal, Investor Relations and administrative functions. Robin brings over twenty years of professional services and financial experience to Versant. Prior to joining Versant in 2000, Robin was a tax partner with Arthur Andersen, and has extensive experience in partnership formation and structuring issues. At Anderson his client base included large real estate partnerships and corporations. Robin received a Bachelor’s degree in Political Economics of Industrial Societies from the University of California, Berkeley, and a Master’s degree in Taxation from Golden Gate University. He is a Certified Public Accountant and a member of the AICPA and the California State Board of Accountancy. Robin currently sits on the Board of the West Coast Chapter of the Private Equity Chief Financial Officer Association and is a member of the NVCA CFO Task Force.
Follow Robin L. Praeger:
About Versant Ventures: Versant Ventures caters to the healthcare sector with early and later stage venture, private equity, and debt financing investments.
Spencer Lee
CFO of Hims & Hers
Follow Spencer Lee:
About Hims & Hers: Hims is a wellness brand that helps men and women get access to products for skin care, hair loss, and sexual health.
Tobias Mezger
Co-Founder – COO/CFO of PayZen
I am passionate about solving big problems by making financial services more straightforward and more accessible. I am excited about building a great company.
Follow Tobias Mezger:
About PayZen: PayZen is a health care fintech startup that aims to tackle the growing patient payment responsibility problem.
Rick Kent
CFO of Paramit Corporation
Rick Kent is the Chief Financial Officer at Paramit Corporation.
Follow Rick Kent:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Tom LaRose
CFO of Paramit Corporation
Tom LaRose is CFO at Paramit Corporation.
Follow Tom LaRose:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
David Cristman
Chief Financial Officer of ClearCare
Follow David Cristman:
About ClearCare, ClearCare: ClearCare is a web-based software solution that helps home care agencies efficiently focus on what’s important: providing better care.
Glenn S. Boehnlein
Chief Financial Officer & Vice President of Stryker
Follow Glenn S. Boehnlein:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Susan M. Kanaya
Senior Vice President, Finance, Chief Financial Officer and Secretary of ChemoCentryx
Ms. Susan M. Kanaya has served as our Senior Vice President, Finance, and Chief Financial Officer since January 2006, and Secretary since February 2006. Prior to joining us, Ms. Kanaya served as Senior Vice President, Finance, and Chief Financial Officer at Kosan Biosciences Inc., a biotechnology company, from 1999 to 2005. Prior to this, she served in financial management positions at SUGEN, Inc., a biotechnology company, from 1994 to 1999, most recently as Vice President, Finance, and Treasurer. Ms. Kanaya also served as Controller with high technology companies and as a public accountant with KPMG. Ms. Kanaya received her B.S. in business administration from the University of California, Berkeley.
Follow Susan M. Kanaya:
About ChemoCentryx: ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.
Brian Jung
CFO of AiCure
Brian Jung is the CFO of AiCure.
Follow Brian Jung:
About AiCure: AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
Bryan Giraudo
Chief Financial Officer & COO of Gossamer Bio
Mr. Giraudo is the Chief Financial Officer of Gossamer Bio. Previously, he was Senior Managing Director at LEERINK Partners, where he was responsible for LEERINK’s Western North America and Asia life sciences investment banking practice. Prior to joining LEERINK Partners in 2009, Bryan was a Managing Director in Merrill Lynch’s Global Healthcare Investment Banking Group. Bryan received his B.A. from Georgetown University.
Follow Bryan Giraudo:
About Gossamer Bio: Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Lee Raymundo
CFO of Redox
Lee Raymundo is the CFO at Redox.
Follow Lee Raymundo:
About Redox: Redox is an EHR integration and healthcare platform that accelerates the development and distribution of healthcare software solutions.
Jeff Pashalides
Chief Financial Officer of Nomi Health
Follow Jeff Pashalides:
About Nomi Health: Nomi Health is a direct health company that aims to reduce the cost of health care for employers and patients.
Leo Popov
Founder, CFO, Product & Growth TrueCare24 | 500 Startups Batch 20 Company of TrueCare24
CEO & Co-Founder of TrueCare24.
Follow Leo Popov:
About TrueCare24: In-Home Senior Care Automation Platform
Paul Manners
Chief Financial Officer of Trak
Follow Paul Manners:
About Trak: Sandstone Diagnostics provides an integrated wellness technology that empowers consumers to measure, monitor, and improve their health.
John Maley
Chief Financial Officer of AliveCor
Follow John Maley:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Laura Francis
Chief Financial Officer of SI-BONE
Laura A. Francis has served as our Chief Financial Officer since May 2015. Prior to joining SI BONE, Ms. Francis was the Chief Financial Officer for Auxogyn, Inc., a women’s health company, from December 2012 to September 2014. From September 2004 to December 2012, Ms. Francis served as Vice President of Finance, Chief Financial Officer and Treasurer for Promega Corporation, a life science reagent company. From March 2002 to September 2004, Ms. Francis served as the Chief Financial Officer of Bruker BioSciences Corporation, a public life science instrumentation company. From May 2001 to March 2002, Ms. Francis served as Chief Operating Officer and Chief Financial Officer of Nutra-Park Inc., an agricultural biotechnology company. From April 1999 to May 2001, Ms. Francis was Chief Financial Officer of Hypercosm, Inc., a software company. From October 1995 to April 1999, Ms. Francis was an engagement manager with McKinsey & Company, a consulting firm. Early in her career, Ms. Francis was an audit manager with Coopers & Lybrand, an accounting firm. Ms. Francis received a B.B.A. from the University of Wisconsin and an M.B.A. from Stanford University. She is a Certified Public Accountant (inactive) in the State of California.
Follow Laura Francis:
About SI-BONE: SI-BONE advances the diagnostic understanding of lower back pain and minimally invasive surgery for the sacroiliac joint.
Nathan Weems
Chief Financial Officer of VitalConnect
Nathan has accrued over 13 years of operational excellence in management roles spanning finance, business development, and marketing, most recently serving as Sr. Director of Finance at Natera, a public Bay Area biotech company. Earlier experience includes tenure at a top Wall Street investment bank and Big-4 accounting firm. Nathan brings expertise in accounting, due diligence, market research, fund raising and investor relations. He holds a BA from the University of Southern California and an MBA from Wharton. When his HP 12C is not within reach, you can usually find Nathan on two wheels or two skis exploring the outdoors with his family.
Follow Nathan Weems:
About VitalConnect: VitalConnect is a wearable biosensor technology for wireless hospital and remote patient monitoring.
Raj Matthew
Chief Financial Officer of Doctor Direct
Raised $1.2BB in public/private placements and negotiated over $1.3BB in transactions at Asante Technologies, PeopleWeb Communications and Vivato Networks. As CFO for Asante Technologies exceeded analyst expectations on turnaround plan while tripling analyst coverage. As CFO, led IPO process at PeopleWeb Communications, positioned company to analysts and investment bankers. Part of senior finance team that led the spin-off of PacTel Corporation, (Vodafone Airtouch) in the 4th largest IPO in US history, concurrent with a billion dollar debt offering. As VP Finance & Controller, led M&A team that managed a total of 10 mergers/acquisitions (4 public, 6 private companies) in 26 months at Avant!-Synopsys, while company grew to 42 offices in 16 countries, over 1000 employees, annual bookings in excess of $400 MM. Arranged $700MM in syndicated financing and refinanced $250MM in convertible bonds at Conner-Seagate during explosive growth, (reached $1.2BB in revenue in 13 months).
Follow Raj Matthew:
About Doctor Direct: Doctor Direct is an exciting company in the rapidly expanding Healthcare – remote patient monitoring space.
Tom O’Neil
Chief Financial Officer of Protagonist Therapeutics
Tom O’Neil is the chief financial officer of [Arcadia Biosciences](https://www.crunchbase.com/organization/arcadia-biosciences#/entity), an agricultural technology company focused on developing products that benefit the environment and human health. Prior to that, he held the same position at Sorbent Therapeutics. O’Neil has also served as the vice president of finance and marketing at ChemGenex Pharmaceuticals and as a team member at HX Diagnostics. O’Neil holds a bachelor’s degree in international relations from Pomona College and master’s degree in business administration from the University of California, Los Angeles. He lives in San Francisco, California, United States.
Follow Tom O’Neil:
About Nodality, Protagonist Therapeutics: Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Christopher Senner
Executive Vice President and Chief Financial Officer of Exelixis
Chris Senner is Executive Vice President and Chief Financial Officer at Exelixis. Since July 2015, Mr. Senner has held this role with responsibility for ensuring the prudent management of the company’s assets, allowing Exelixis to invest in its proprietary and partnered molecules, launch new indications and otherwise advance its important work in the treatment of cancer. Prior to joining Exelixis, Mr. Senner served as Vice President, Corporate Finance at Gilead Sciences, Inc., which he joined in March 2010. At Gilead, he was accountable for controllership, tax, treasury and corporate and operational financial planning. Before joining Gilead, Mr. Senner spent 18 years at Wyeth in a variety of financial roles with increasing responsibility, most notably as Chief Financial Officer of Wyeth’s U.S. pharmaceuticals business and the BioPharma business unit. Mr. Senner holds a B.S. in Finance from Bentley College.
Follow Christopher Senner:
About Exelixis: Exelixis works is focused on discovering, developing and commercializing therapies for the treatment of cancer and other serious diseases.
McDavid Stilwell
Chief Financial Officer of Coherus Biosciences
McDavid Stilwell is the Chief Financial Officer at Coherus BioSciences.
Follow McDavid Stilwell:
About Coherus Biosciences: Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Jeffrey H. Cooper
Chief Financial Officer of Humanigen
Follow Jeffrey H. Cooper:
About Humanigen, Sierra Oncology: Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.
Matteo Marchetta
CFO of Augmedix
Matteo comes to Altiscale from Exigen Capital, where he was the operating partner leading finance in early and growth-stage SaaS portfolio companies. Previously, as CFO he led the turnaround and growth of Tie Rack and Rolling Luggage group, a multinational retailer based in London. His background is in consulting with Boston Consulting Group, where he delivered growth strategies for large corporations in the IT and retail markets and as an engineer in the telecommunications industry. He holds an MBA from IESE Business School in Barcelona and a master’s in electronic engineering with a specialization in computer science.
Follow Matteo Marchetta:
About Altiscale, Augmedix: Augmedix is a tech-enabled service that allows doctors to focus on what matters most: patient care.
John Beck
Acting Chief Financial Officer of AEGEA Medical
John started BeckCFO in 2007 and brings over 30 years of experience in financial management, strategic planning and execution for technology firms. John has worked with early stage companies in life sciences (medical device and pharmaceutical), fabless semiconductor, software and software as a service, hardware systems, and services. John has held full-time CFO positions with both public and private companies, and, in addition to finance, has broad experience managing cross-functional areas such as IP management, legal, treasury, risk management, HR, IT and facilities. John’s background also includes managing the accounting, finance and reporting requirements of European and Asian offices. Before starting BeckCFO, John previously served as CFO for several companies including: Silicon Bandwidth, Inc., nDSP Corporation (acquired by PixelWorks), Sigma Designs, Inc., Augeo Software, Meta-Software, Inc. (acquired by Synopsys), Sellectek Incorporated, RayLAN Corporation, Optimem and Spectra Logic subsidiaries of Cipher Data Products, and Minton Company. Prior to his tenure at technology firms, John held senior audit positions at Ernst & Young and KPMG Peat Marwick certified public accounting firms. John earned a B.S. degree in Commerce with an Accounting emphasis, cum laude, from Santa Clara University. He is also a licensed C.P.A. (inactive), with the State of California.
Follow John Beck:
About AEGEA Medical, CloudPhysics: AEGEA Medical manufactures surgical and medical instruments.
Scott Gorton
CFO of Apton Biosystems
Follow Scott Gorton:
About Apton Biosystems, Cloudleaf, Precursor Energetics: Apton Biosystems develops a high-throughput and low-cost sequencing platform that revolutionizes the availability of genetic analysis.
Reynold Samoranos
Chief Financial Officer of PX6 Medical Systems
Mr. Samoranos has been a Chief Financial Officer since 1991. He is recognized for his domestic and global leadership in financial, operational, investments, and strategic business management. He recently worked at CFO COO Consultants, Inc. as a CFO Management Consultant, working with start-ups, non-profits, private companies, and the government. Before CFO COO Consultants, Reynold worked for various institutional Investment Firms as the Chief Financial Officer, COO, and CCO, including – Hanson Investment Management Company, a $2.5 Billion domestic equity firm, Newport Pacific Management Company, a $3.0 billion international investment firm, and Hammerman Capital Management, LLC, an Opportunity hedge fund. Reynold received his bachelor’s of science degree in Business Administration from the Haas Business School at the University of California, Berkeley, and an MBA in finance and international business from the Booth Business School at the University of Chicago.
Follow Reynold Samoranos:
About PX6 Medical Systems: A CONTEMPORARY “LOGISTICS” FOR 21ST-CENTURY HEALTHCARE.”
Graham Cooper
COO, CFO of Assembly Biosciences
Graham Cooper joined us as Chief Financial Officer in February 2013. Prior to joining us, during 2012, Graham Cooper was the Executive Vice President, Finance and Chief Financial Officer of Geron Corporation, a biopharmaceutical company focused on cancer therapies. From 2006 until 2011, Graham Cooper served as Senior Vice President, Chief Financial Officer and Treasurer of Orexigen Therapeutics, Inc., a biotechnology company focused on obesity. From 1999 to 2006, Graham Cooper held positions of increasing responsibility including Director, Health Care Investment Banking, at Deutsche Bank Securities, where he was responsible for executing and managing a wide variety of financing and merger and acquisition transactions in the life sciences field. From August 1992 to January 1995, he worked as an accountant at Deloitte & Touche, and was previously a C.P.A. Graham Cooper holds a B.A. in Economics from the University of California at Berkeley and an M.B.A. from the Stanford Graduate School of Business.
Follow Graham Cooper:
About Assembly Biosciences, Beam Therapeutics: Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.
John Borgeson
Chief Financial Officer of ALX Oncology
John Borgeson is our Chief Financial Officer and has served in this position since June 2014. Borgeson brings over 25 years of pharmaceutical industry experience in finance, strategy and operations on a global scale. Previously Borgeson was a Vice President of Finance at Pfizer and a member of Pfizer’s Global Financial Leadership Team. Borgeson’s roles at Pfizer included CFO for Pfizer’s biotherapeutics division and corporate tax executive with responsibility for US and Europe. Under Borgeson’s leadership, Pfizer completed a transformational restructuring of the global tax group that was replicated by other Fortune 50 companies. Borgeson has more recently led finance for a variety of private biotech companies, including Labrys Biologics, which was acquired by Teva Pharmaceuticals for $825 million. He was also CFO of venBio, a venture capital firm with a strong track record in biotechnology investing. Borgeson started his career as an auditor with Ernst & Young and is a certified public accountant. He has an M.B.A. from R.I.T. and an undergraduate degree from the School of Management at the University at Buffalo (S.U.N.Y.).
Follow John Borgeson:
About ALX Oncology, Kodiak Sciences: ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Anthony M. Rimac
Chief Financial Officer of Cognoa
Follow Anthony M. Rimac:
About Cognoa: Cognoa is a behavioral health company focused on improving the lives and outcomes of children and families living with behavioral conditions
Sid Hartman
Chief Financial and Operating Officer of Marin Community Foundation
Sid joined the Foundation in 1997 as Vice President for Finance and Administration and in 2008 assumed his current position. For the prior 11 years, Sid was Vice President, Finance and Administration at the Minneapolis Foundation. He has also held various positions, including executive director, at the Challenge Center in Wisconsin, which served developmentally disabled adults and infants. He graduated from the University of Wisconsin.
Follow Sid Hartman:
About Marin Community Foundation: The Marin Community Foundation helps people make their charitable giving more effective and more personally satisfying.
Beth Gray
CFO of Cogitativo
Beth Gray has been serving as vice-president of finance of Cogitativo since January 2018.
Follow Beth Gray:
About Cogitativo: Cogitativo is a machine learning enterprise offering world class solutions to hospitals, physicians, and payers.
Greg Curhan
Chief Financial Officer and SVP of Corporate Development of Providence Medical Technology
Greg is an experienced corporate executive and entrepreneur, as well as a capital markets and strategic advisory expert. He brings over 30 years of experience leading and advising fast-growing companies in the medical and information technology sectors to Providence. Greg has served as Chief Financial Officer of both public and private companies. Prior to joining Providence Medical Technology Greg Curhan served as a founder and past President of Merriman Curhan Ford, a leading San Francisco-based investment bank that supported venture-backed, high-growth companies in Silicon Valley, raised over $5 billion dollars for its corporate clients and advised on numerous mergers and acquisitions. Greg is a graduate of Dartmouth College where he earned a BA in Economics and graduated Summa Cum Laude.
Follow Greg Curhan:
About Providence Medical Technology: Providence Medical Technology is a privately-held medical device company focused on innovative solutions for cervical spinal conditions.
Ronald Jabba
CEO, Acting CFO of ProMed
Mr. Ronald Jabba serves as a Chief Executive Officer and Director at ProMed Inc.
Follow Ronald Jabba:
About ProMed, Zenflow: ProMed provides billing, credentialing, and contracting services in the healthcare sector.
Lindsey Newton
Advisory CFO of Prescribe Nutrition
Follow Lindsey Newton:
About : Prescribe Nutrition offers a revolutionary, on demand approach to nutrition and wellness counseling.
David Olson
CFO of Heads Up Health
David Olson is a CFO at Heads Up Health.
Follow David Olson:
About Heads Up Health: Heads Up Health help individuals, sports teams and healthcare professionals make better decisions using data.
Scott Lipsitz
Co-Founder and CFO of Arkos Health
Scott Lipsitz is the Co-Founder and CFO of Arkos Health.
Follow Scott Lipsitz:
About Arkos Health, Driver Studios, Rainmaker Capital: Arkos Health aligns various points of care to connect and transform the current healthcare system through Technology, People and Processes
Michael Farrow
CFO of PipelineRx
Mr. Farrow is a seasoned Financial leader with over 20 years of experience driving improved financial performance across a wide range of industries. Prior to joining PipelineRx, Mike served as a CFO for CloudMade, a leader in location based technologies working with the world’s leading automotive and consumer electronics OEMs. Previously, he served as CFO for leading digital media companies NetShelter Technology Media and Jumpstart Automotive Media which deliver internet advertising across technology and automotive-related websites, respectively. He was also the top Financial Manager for fastest growing division at EarthLink, a Fortune 1000 company. Mr. Farrow earned a B.S. in Finance from the University of Arizona and has his M.B.A. from the USC Marshall School of Business.
Follow Michael Farrow:
About PipelineRx: PipelineRx is a clinical telepharmacy services company that offers clinical telepharmacist teams to its hospital clients.
Michael Byrnes
Chief Financial Officer of Effector Therapeutics
Michael Byrnes joined eFFECTOR Therapeutics as Chief Financial Officer in 2020.
Follow Michael Byrnes:
About Effector Therapeutics: Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Paul A. Stone
Chief Financial Officer & General Counsel of IDEAYA Biosciences
Stone Paul A. joined IDEAYA Biosciences as Chief Financial Officer, General Counsel in 2018.Paul A. Stone, J.D. joined 5AM Ventures in July 2009 as General Counsel and Chief Operating Officer. In addition to his legal and operational responsibilities, he serves as a Board Observer at Kinestral, Rennovia and Wildcat. Mr. Stone has held managerial and operating roles at several private and public biopharmaceutical companies. Most recently he was General Counsel and Senior VP Intellectual Property at Ethos Pharmaceuticals. Previously he was Senior VP, General Counsel, and Chief Patent Counsel at Ilypsa (acquired by Amgen). Prior to Ilypsa, he was VP, Chief Patent Counsel for Symyx (IPO in 1999). Mr. Stone received his J.D. from the University of Wisconsin Law School in 1995 and practiced as a Patent Attorney at Senniger, Powers, Leavitt & Roedel. He taught patent law, trade secrets law and licensing as an adjunct professor at the University of Missouri and Santa Clara University.
Follow Paul A. Stone:
About 5AM Ventures, IDEAYA Biosciences: IDEAYA Biosciences is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality
Christopher Baker
CFO of Goodwill of Silicon Valley
Follow Christopher Baker:
About Goodwill of Silicon Valley: Goodwill of Silicon Valley is to improving the quality of life for all residents of Silicon Valley.
Boyd Faust
Chief Financial Officer of GoHealth Urgent Care
Follow Boyd Faust:
About Access Clinical Partners, GoHealth Urgent Care: Access Clinical Partners owns and operates urgent care centers to provide healthcare services to patients.
Kent Elmer
CFO of PokitDok
Kent joined PokitDok as Chief Financial Officer, following the close of an oversubscribed $34M Series B round of equity funding in August 2015. A Certified Public Accountant (CPA) with 20+ years specializing in finance and operations, he has broad-based experience ranging from Big 4 public accounting to CFO level positions at a variety of companies. His public company experience includes CFO of IQ Software Corporation, a NASDAQ company.
Follow Kent Elmer:
About PokitDok, TechCXO: PokitDok provides a software development platform with a set of APIs that streamlines the basic business processes of healthcare.
Zack McNealy
CFO of Inception Sciences
Zack McNealy joined Ventus Therapeutics as CFO in 2019.Zack McNealy is the Vice President, Finance responsible for Versant’s domestic and international management company entities. Zack also works extensively with a number of Versant’s biotech portfolio companies on their international structuring and operational setup. Zack joined Versant after spending seven years at Biotie Therapies (formerly Synosia Therapeutics) where he was Vice President, Finance supporting the U.S. and Swiss operations of the company. Prior to Biotie, Zack spent ten years at Johnson & Johnson as Plant Controller, Finance Manager and Financial Analyst. Zack received an MBA from the Wharton School, University of Pennsylvania and a BS in finance and accounting from Miami University (Ohio).
Follow Zack McNealy:
About Inception Sciences, Ventus Therapeutics: Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Mark Tao
Chief Financial Officer of Wu Yee Children’s Services
Mark Tao is Director of Finance at Fort Mason Center.
Follow Mark Tao:
About Wu Yee Children’s Services: Wu Yee Children’s Services is a non-profit social service agency that provides child care and education for children.
Jeet Mahal
Chief Financial and Business Officer of Jasper Therapeutics
Jeet Mahal is the Chief Financial and Business Officer at Jasper Therapeutics.
Follow Jeet Mahal:
About Jasper Therapeutics: Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic.
